MedPath

Bevenopran

Generic Name
Bevenopran
Drug Type
Small Molecule
Chemical Formula
C20H26N4O4
CAS Number
676500-67-7
Unique Ingredient Identifier
IC58Q2EHPJ

Overview

Bevenopran has been used in trials studying the treatment of Renal Impairment and Opioid-Induced Constipation.

Background

Bevenopran has been used in trials studying the treatment of Renal Impairment and Opioid-Induced Constipation.

Indication

No indication information available.

Associated Conditions

No associated conditions information available.

Clinical Trials

Single Oral Dose of Bevenopran in Patients With Varying Degrees of Renal Impairment
Phase 1
Terminated
Posted: 2015/07/27
Sponsor:
Cubist Pharmaceutica...
ID:NCT02508740
The Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3
Terminated
Posted: 2013/07/17
Sponsor:
Cubist Pharmaceutica...
ID:NCT01901341
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3
Terminated
Posted: 2013/07/17
Sponsor:
Cubist Pharmaceutica...
ID:NCT01901302
Efficacy and Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3
Terminated
Posted: 2013/07/17
Sponsor:
Cubist Pharmaceutica...
ID:NCT01901328
Safety Study of CB-5945 for the Treatment of Opioid-Induced Constipation
Phase 3
Terminated
Posted: 2012/10/01
Sponsor:
Cubist Pharmaceutica...
ID:NCT01696643

FDA Approved Products

No FDA products found for this drug

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy